Daily aspirin reduced by 55% the risk of cancer recurrence in patients whose colorectal cancer is driven by a genetic ...

A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...

Scientists have demonstrated that a common blood thinner is more effective than aspirin—and just as safe—for patients with ...

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...

A groundbreaking new clinical trial has found that taking a low dose of the common fever medicine Aspirin halves the risk of ...

Early P2Y12 monotherapy after PCI for acute coronary syndrome was not noninferior compared with dual antiplatelet therapy ...

Emerging evidence suggests a better option already exists. A recent meta-analysis by an international team of cardiologists finds that clopidogrel – which stops blood platelets from clumping – is a ...

The painkilling, antipyretic, and antiinflammatory properties of aspirin have been known for centuries. The understanding that aspirin targets cyclooxygenase-1 (COX-1) (also known as ...

Aspire’s sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes ...

New study suggests differences between coated versus non-coated aspirin. Dec. 5, 2012— -- Coated aspirin may lose some of its cardiovascular benefits because it takes longer for the drug to ...